Európska únia - slovenčina - EMA (European Medicines Agency)

anamorelin hydrochlorid - cachexia; anorexia; carcinoma, non-small-cell lung - všetky ostatné terapeutické produkty - liečba anorexia, cachexia alebo nechcený úbytok hmotnosti u dospelých pacientov s non-small cell lung cancer (nsclc).

Európska únia - slovenčina - EMA (European Medicines Agency)

h. lundbeck a/s - memantine hydrochlorid, donepezil hydrochlorid - alzheimerova choroba - treatment of alzheimers disease.

Európska únia - slovenčina - EMA (European Medicines Agency)

merz pharmaceuticals gmbh - memantine hydrochlorid, donepezil hydrochlorid - alzheimerova choroba

Európska únia - slovenčina - EMA (European Medicines Agency)

bristol-myers squibb pharma eeig - ozanimod hydrochlorid - multiple sclerosis, relapsing-remitting; colitis, ulcerative - imunosupresíva - multiple sclerosiszeposia is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis (rrms) with active disease as defined by clinical or imaging features. ulcerative colitiszeposia is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis (uc) who have had an inadequate response, lost response, or were intolerant to either conventional therapy or a biologic agent.

Slovensko - slovenčina - myHealthbox

bayer ag - dispergovateľný koncentrát - fluopicolide 62,5 g/l; propamocarb - hydrochlorid 625 g/l

Európska únia - slovenčina - EMA (European Medicines Agency)

accord healthcare s.l.u. - doxorubicin hydrochloride, liposomal - ovarian neoplasms; sarcoma, kaposi; multiple myeloma - doxorubicin - zolsketil pegylated liposomal is a medicine used to treat the following types of cancer in adults:• breast cancer that has spread to other parts of the body in patients at risk of heart problems. zolsketil pegylated liposomal is used on its own for this disease;• advanced ovarian cancer in women whose previous treatment including a platinum-based cancer medicine has stopped working;• multiple myeloma (a cancer of the white blood cells in the bone marrow), in patients with progressive disease who have received at least one other treatment in the past and have already had, or are unsuitable for, a bone marrow transplantation. zolsketil pegylated liposomal is used in combination with bortezomib (another cancer medicine);• kaposi’s sarcoma in patients with aids who have a very damaged immune system. kaposi’s sarcoma is a cancer that causes abnormal tissue to grow under the skin, on moist body surfaces or on internal organs. zolsketil pegylated liposomal contains the active substance doxorubicin and is a ‘hybrid medicine’. this means that it is similar to a ‘reference medicine’ containing the same active substance called adriamycin. however, in zolsketil pegylated liposomal the active substance is enclosed in tiny fatty spheres called liposomes, whereas this is not the case for adriamycin.

Slovensko - slovenčina - myHealthbox

bayer ag - dispergovateľný koncentrát - fluopicolide 62,5 g/l; propamocarb - hydrochlorid 625 g/l

Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

warszawskie zaklady farmaceutyczne polfa s.a., poľsko - naloxón - 19 - antidota, detoxicantia

Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

m.c.m. klosterfrau vertriebsgesellschaft mbh, nemecko - oktenidín - 32 - antiseptica, desinficientia (lokÁlne)